A Clinical Carbapenem-Resistant Acinetobacter baylyi Strain

26 blaSIM-1 and blaOXA-23 were co-detected in a clinical carbapenem-resistant 27 Acinetobacter baylyi strain NB09A30. Both of carbapenemase genes were located on 28 a ca. 360 kb large plasmid. blaSIM-1 was found as a gene cassette inserted into a class 1 29 integron identical to that determined in Acinetobacter spp. isolates from South Korea. 30 The genetic structure of blaOXA-23 in NB09A30 was different from that in the 31 prevalent Acinetobacter baumannii of CC92 from the same hospital. 32

[1]  Qing Yang,et al.  Genomic Analysis of the Multidrug-Resistant Acinetobacter baumannii Strain MDR-ZJ06 Widely Spread in China , 2011, Antimicrobial Agents and Chemotherapy.

[2]  Songnian Hu,et al.  Genomic analysis of the multi-drug resistant Acinetobacter 1 baumannii strain MDR-ZJ 06 widely spread in China 2 3 , 2011 .

[3]  Chang Ki Kim,et al.  Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-beta-lactamases. , 2010, International journal of antimicrobial agents.

[4]  Alessandra Carattoli,et al.  Characterization and PCR-Based Replicon Typing of Resistance Plasmids in Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.

[5]  Qing Yang,et al.  Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. , 2010, The Journal of antimicrobial chemotherapy.

[6]  K. Towner.  Acinetobacter: an old friend, but a new enemy. , 2009, The Journal of hospital infection.

[7]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[8]  L. Rice,et al.  Cotransfer of Antibiotic Resistance Genes and a hylEfm-Containing Virulence Plasmid in Enterococcus faecium , 2009, Antimicrobial Agents and Chemotherapy.

[9]  P. Courvalin,et al.  GES-11, a Novel Integron-Associated GES Variant in Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.

[10]  Carlene A. Muto,et al.  Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania , 2008, Antimicrobial Agents and Chemotherapy.

[11]  Te‐Li Chen,et al.  Acinetobacter baylyi as a Pathogen for Opportunistic Infection , 2008, Journal of Clinical Microbiology.

[12]  R. Seviour,et al.  Unique organization of the 16S-23S intergenic spacer regions of strains of Acinetobacter baylyi provides a means for its identification from other Acinetobacter species. , 2008, Journal of microbiological methods.

[13]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[14]  M. Kaufmann,et al.  Identification of Acinetobacter baumannii by Detection of the blaOXA-51-like Carbapenemase Gene Intrinsic to This Species , 2006, Journal of Clinical Microbiology.

[15]  G. Rossolini,et al.  Novel Acquired Metallo-β-Lactamase Gene, blaSIM-1, in a Class 1 Integron from Acinetobacter baumannii Clinical Isolates from Korea , 2005, Antimicrobial Agents and Chemotherapy.

[16]  F. Rodríguez-Valera,et al.  Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii , 2005, Journal of Clinical Microbiology.

[17]  M. Vaneechoutte,et al.  Species-Level Identification of Isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex by Sequence Analysis of the 16S-23S rRNA Gene Spacer Region , 2005, Journal of Clinical Microbiology.